Estimates of breast cancer screening benefit in older women to inform patient-centered care

PURPOSE: When to stop breast cancer screening remains uncertain. The USPSTF recommends screening to age 74. Modeling estimates on screening benefit after age 74 are 5-12 average life-years gained (LYG) per 1000 women, which may be a useful benchmark for considering stopping screening. Existing LYG estimates do not incorporate individualized cancer risk or individualized life expectancy and involve numerous assumptions in simulation models. We aimed to estimate screening benefit in older women that incorporate frailty/comorbidity and breast cancer risk. METHODS: Using SEER-Medicare data (1999-2017), we constructed cohorts to estimate screening benefit at age 70 and 75, respectively. We included women continuously enrolled in fee-for-service Medicare for ≥5 years and were breast cancer free before the age of interest. We obtained screening-associated breast cancer mortality risk reductions from a previous emulated trial. We combined these with individualized breast cancer mortality risk and individualized competing mortality risk to calculate average LYG from continuing annual screening over 8 years. Estimates were stratified by race and comorbidity/frailty. RESULTS: Average LYG from screening ranged from 4.7-20.5 life-years per 1000 women in the age 70 cohort (n = 204,288), 3.4-13.6 life-years per 1000 women in the age 75 cohort (n = 193,398). Those with higher comorbidities/frailty had lower average LYG. Those with Hispanic/Asian/other race had the lowest LYG whereas Black women had the highest LYG. CONCLUSION: Average LYGs from breast cancer screening based on population level data are small in older women, with important variations by health status and race, which should be considered in clinical discussions and screening recommendations.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2026-11-17
DOI
https://doi.org/10.1093/jnci/djag445
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Estimates of breast cancer screening benefit in older women to inform patient-centered care

Hormuzd A. Katki, Amanda L. Blackford, Li C. Cheung, Ravi Varadhan et al.
JNCI Journal of the National Cancer Institute
Global Cancer Incidence and Screening
article

Estimates of breast cancer screening benefit in older women to inform patient-centered care

Hormuzd A. Katki, Amanda L. Blackford, Li C. Cheung, Ravi Varadhan, Nancy L. Schoenborn
article en

Abstract

PURPOSE: When to stop breast cancer screening remains uncertain. The USPSTF recommends screening to age 74. Modeling estimates on screening benefit after age 74 are 5-12 average life-years gained (LYG) per 1000 women, which may be a useful benchmark for considering stopping screening. Existing LYG estimates do not incorporate individualized cancer risk or individualized life expectancy and involve numerous assumptions in simulation models. We aimed to estimate screening benefit in older women that incorporate frailty/comorbidity and breast cancer risk. METHODS: Using SEER-Medicare data (1999-2017), we constructed cohorts to estimate screening benefit at age 70 and 75, respectively. We included women continuously enrolled in fee-for-service Medicare for ≥5 years and were breast cancer free before the age of interest. We obtained screening-associated breast cancer mortality risk reductions from a previous emulated trial. We combined these with individualized breast cancer mortality risk and individualized competing mortality risk to calculate average LYG from continuing annual screening over 8 years. Estimates were stratified by race and comorbidity/frailty. RESULTS: Average LYG from screening ranged from 4.7-20.5 life-years per 1000 women in the age 70 cohort (n = 204,288), 3.4-13.6 life-years per 1000 women in the age 75 cohort (n = 193,398). Those with higher comorbidities/frailty had lower average LYG. Those with Hispanic/Asian/other race had the lowest LYG whereas Black women had the highest LYG. CONCLUSION: Average LYGs from breast cancer screening based on population level data are small in older women, with important variations by health status and race, which should be considered in clinical discussions and screening recommendations.

JNCI Journal of the National Cancer Institute
American Cancer Society (US), Johns Hopkins University (US), Johns Hopkins Medicine (US)
Good health and well-being
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon